Latest News of TBPH
Here's Why We're Not At All Concerned With Theravance Biopharma's (NASDAQ:TBPH) Cash Burn Situation
By Yahoo! Finance |
3 weeks ago
Even if a company is not profitable, its stock may not necessarily decline. For instance, Theravance Biopharma has managed its cash burn effectively, with a solid cash runway and reduced spending. Ana...
Need To Know: Analysts Just Made A Substantial Cut To Their Theravance Biopharma, Inc. (NASDAQ:TBPH) Estimates
By Yahoo! Finance |
1 month ago
Theravance Biopharma, Inc. faced a downgrade in revenue and earnings forecasts by analysts, impacting shareholder sentiment. Despite a cut in estimates, the company is expected to see revenue growth s...
Theravance Biopharma, Inc. (NASDAQ:TBPH): When Will It Breakeven?
By Yahoo! Finance |
2 months ago
Theravance Biopharma, Inc., a biopharmaceutical company focused on respiratory medicines, is expected to reach profitability in 2025 according to industry analysts....
-
Investors in Theravance Biopharma (NASDAQ:TBPH) have unfortunately lost 52% over the last five years
By Yahoo! Finance | 3 months agoTheravance Biopharma, Inc. (NASDAQ: TBPH) has seen a 52% drop in share price over five years due to revenue decline. With no profit growth and revenue shrinkage, it's not an attractive investment curr...